AxoGen (AXGN)
(Delayed Data from NSDQ)
$14.08 USD
-0.59 (-4.02%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $14.09 +0.01 (0.07%) 7:02 PM ET
2-Buy of 5 2
D Value A Growth F Momentum C VGM
Brokerage Reports
0 items in cart
AxoGen, Inc. [AXGN]
Reports for Purchase
Showing records 41 - 60 ( 71 total )
Company: AxoGen, Inc.
Industry: Medical - Generic Drugs
Avance Making Significant Headway With Hand Surgeons; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: AxoGen, Inc.
Industry: Medical - Generic Drugs
HEALTHCARE - 2016 PacGrow Healthcare Conference Day 2
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AxoGen, Inc.
Industry: Medical - Generic Drugs
Medical Devices - Key Takeaways from the PacGrow Healthcare Conference
Provider: WEDBUSH SECURITIES INC.
Company: AxoGen, Inc.
Industry: Medical - Generic Drugs
Major Milestone Achieved With First $10 Million Quarter; Increasing PT to $10 and Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: AxoGen, Inc.
Industry: Medical - Generic Drugs
Medical Devices: 2Q16 MedTech Preview: Stable Trends and Healthy Underlying Fundamentals
Provider: WEDBUSH SECURITIES INC.
Company: AxoGen, Inc.
Industry: Medical - Generic Drugs
AXGN Delivers Another Solid Quarter; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: AxoGen, Inc.
Industry: Medical - Generic Drugs
1Q16 MedTech Preview: Stable Trends; Prefer the Oversold Names With Solid Fundamentals
Provider: WEDBUSH SECURITIES INC.
Company: AxoGen, Inc.
Industry: Medical - Generic Drugs
AxoGen reported strong financial results for their most recent Q4/2015 (December) quarter,
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: WASSERMAN R
Company: AxoGen, Inc.
Industry: Medical - Generic Drugs
4Q Results and 2016 Outlook Ahead of Expectations; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: AxoGen, Inc.
Industry: Medical - Generic Drugs
Company: AxoGen, Inc.
Industry: Medical - Generic Drugs
AxoGen Takes Control of the Peripheral Nerve Repair Market; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: AxoGen, Inc.
Industry: Medical - Generic Drugs
Delivers Another Record Quarter; Raising PT to $7.50; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: AxoGen, Inc.
Industry: Medical - Generic Drugs
3Q15 Preview: MedTech Fundamentals Remain Intact Despite Market Volatility
Provider: WEDBUSH SECURITIES INC.
Company: AxoGen, Inc.
Industry: Medical - Generic Drugs
3Q15 Preview: MedTech Fundamentals Remain Intact Despite Market Volatility
Provider: WEDBUSH SECURITIES INC.
Company: AxoGen, Inc.
Industry: Medical - Generic Drugs
Insights from Two Key Opinion Leaders Regarding AxoGen''s Product Suite for the Treatment of Peripheral Nerve Injuries; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: AxoGen, Inc.
Industry: Medical - Generic Drugs
Insights from Two Key Opinion Leaders Regarding AxoGen''s Product Suite for the Treatment of Peripheral Nerve Injuries; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: AxoGen, Inc.
Industry: Medical - Generic Drugs
Company: AxoGen, Inc.
Industry: Medical - Generic Drugs
Raises $17 Million with Essex Woodlands and Adds Guido Neels to the Board; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: AxoGen, Inc.
Industry: Medical - Generic Drugs
HEALTHCARE: 2015 Wedbush PacGrow Healthcare Conference Day 2
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: AxoGen, Inc.
Industry: Medical - Generic Drugs
Surgeon Awareness
Provider: WEDBUSH SECURITIES INC.